NICHD maternal fetal medicine units network

NICHD母胎医学单位网

基本信息

  • 批准号:
    10254471
  • 负责人:
  • 金额:
    $ 26.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1992
  • 资助国家:
    美国
  • 起止时间:
    1992-04-08 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT This proposal describes the application of The Ohio State University (OSU) Center for continued participation in the Eunice Kennedy Shriver NICHD Maternal Fetal Medicine Units (MFMU) Network. The current application describes our team, environment and resources to meet the objectives of the Network. Since 1992, the OSU Center has demonstrated a strong performance and experience in conducting clinical and translational research based on excellent infrastructure and institutional support. We developed a strong research team led by Maged Costantine, MD who was recruited to the OSU Wexner Medical Center in 2019, as a Division Director for Maternal Fetal Medicine and Principal Investigator for the MFMU Network Center, and Mark Landon, MD who serves as Chair for the Department of OG/GYN and Alternate PI. In addition to productivity in the MFMU Network, both the PI and alternate PI, bring extensive experience in study design, recruitment, data analysis, and publications. The OSU Network will recruit study participants from diverse populations at 3 medical centers with a combined total of more than 15,000 annual births, many of them are high-risk, and the majority receiving prenatal care at the three systems. Our Center Nurse Coordinator, Anna Bartholomew, MPH, RN, BSN, CCRP, leads a large group of faculty & research staff capable of recruiting and retaining patients in the setting of an excellent research organization enhanced by 29 years of experience in the MFMU Network, participation in the NICHD Nulliparous Network, and memberships in the North American Fetal Treatment Network, and Ohio Perinatal Research Network (OPRN). We benefit from a robust bioinformatics structure and versatile Electronic Medical Record System (EMR) that captures antepartum, intrapartum, and postpartum data online and is readily available to authorized research personnel for query as well as automatic notification, an extraordinary group of obstetrical sonographers, perinatal epidemiologists, and a mature research infrastructure supported by a CTSA grant shared with Nationwide Children’s Hospital. Our satellite sites, Miami Valley Hospital in Dayton and Good Samaritan Hospital in Cincinnati, have an outstanding record of recruitment in the most recent Network cycle, well-established research culture, and ambitious goals for MFMU Network participation. Our partnership and strong collaboration with Neonatology at Nationwide Children’s Hospital in clinical care and research, Pathology and Clinical Laboratory add strengths to our application. We look forward to continuing our tradition of service, strong performance, and innovation in the next cycle of the NICHD MFMU Network. We accept the RFA’s capitation and participatory stipulations and stand ready to achieve the goals of the Network in completion of the ongoing studies in a collaborative way across all research centers.
摘要 本提案描述了俄亥俄州州立大学(OSU)中心继续参与的申请 Eunice Kennedy Shriver NICHD产妇胎儿医学单位(MFMU)网络。当前应用程序 描述了我们的团队、环境和资源,以实现网络的目标。自1992年以来,OSU 中心在开展临床和转化方面表现出强大的表现和经验 研究基于良好的基础设施和机构支持。我们建立了一个强大的研究团队, 由Maged Costantine博士于2019年被招募到OSU Wexner医疗中心,作为一个部门 产妇胎儿医学主任和MFMU网络中心的首席研究员,马克 Landon,MD,他担任OG/GYN部门的主席和候补PI。除了生产力, MFMU网络,包括PI和替代PI,在研究设计,招募,数据 分析和出版物。OSU网络将在3岁时从不同人群中招募研究参与者 医疗中心每年总共有超过15,000名新生儿,其中许多是高风险的, 大多数人在三个系统接受产前护理。我们的中心护士协调员,安娜巴塞洛缪, MPH,RN,BSN,CCRP,领导着一大批能够招聘和留住教师和研究人员的团队 患者在一个优秀的研究机构的设置增强了29年的经验,在MFMU 网络,参与NICHD无产网络,并成为北美胎儿组织的成员 治疗网络和俄亥俄州围产期研究网络(OPRN)。我们受益于强大的生物信息学 结构化和多功能的电子医疗记录系统(EMR),可记录产前、产时和 产后数据在线,并随时可供授权的研究人员查询,以及自动 通知,一个非凡的产科超声医师,围产期流行病学家,和一个成熟的 研究基础设施由CTSA赠款与全国儿童医院共享支持。我们的卫星 位于代顿的迈阿密山谷医院和位于辛辛那提的好撒玛利亚医院都有出色的记录 在最近的网络周期,良好的研究文化和雄心勃勃的目标,招聘 MFMU网络参与。我们的伙伴关系和强大的合作与新生儿在全国范围内 儿童医院在临床护理和研究、病理学和临床检验等方面为我们增添了实力 应用程序.我们期待着继续我们的服务传统,强大的性能和创新, NICHD MFMU网络的下一个周期。我们接受RFA的人头和参与规定, 随时准备以合作方式完成正在进行的研究,以实现网络的目标 所有研究中心。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Maged Costantine其他文献

Maged Costantine的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Maged Costantine', 18)}}的其他基金

Developing Extracellular Vesicle Based MPRINT Translational Resource Platform for Monitoring Therapeutics Response During Pregnancy
开发基于细胞外囊泡的 MPRINT 转化资源平台,用于监测妊娠期间的治疗反应
  • 批准号:
    10747545
  • 财政年份:
    2023
  • 资助金额:
    $ 26.98万
  • 项目类别:
1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk women
1/2 普伐他汀预防高危女性先兆子痫的随机对照试验
  • 批准号:
    10705607
  • 财政年份:
    2019
  • 资助金额:
    $ 26.98万
  • 项目类别:
1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk women
1/2 普伐他汀预防高危女性先兆子痫的随机对照试验
  • 批准号:
    10087196
  • 财政年份:
    2019
  • 资助金额:
    $ 26.98万
  • 项目类别:
1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk women
1/2 普伐他汀预防高危女性先兆子痫的随机对照试验
  • 批准号:
    10162643
  • 财政年份:
    2019
  • 资助金额:
    $ 26.98万
  • 项目类别:
1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk women
1/2 普伐他汀预防高危女性先兆子痫的随机对照试验
  • 批准号:
    10455106
  • 财政年份:
    2019
  • 资助金额:
    $ 26.98万
  • 项目类别:
NICHD Maternal Fetal Medicine Units Network
NICHD 母胎医学单位网络
  • 批准号:
    9891074
  • 财政年份:
    1992
  • 资助金额:
    $ 26.98万
  • 项目类别:
NICHD maternal fetal medicine units network
NICHD母胎医学单位网
  • 批准号:
    10681772
  • 财政年份:
    1992
  • 资助金额:
    $ 26.98万
  • 项目类别:
NICHD maternal fetal medicine units network
NICHD母胎医学单位网
  • 批准号:
    10379413
  • 财政年份:
    1992
  • 资助金额:
    $ 26.98万
  • 项目类别:
Comprehensive evaluation of the safety and utility of pravastatin in prevention of preeclampsia in high-risk pregnant women
普伐他汀预防高危孕妇子痫前期的安全性和有效性综合评价
  • 批准号:
    9119186
  • 财政年份:
  • 资助金额:
    $ 26.98万
  • 项目类别:

相似海外基金

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 26.98万
  • 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
  • 批准号:
    10738120
  • 财政年份:
    2023
  • 资助金额:
    $ 26.98万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10526768
  • 财政年份:
    2022
  • 资助金额:
    $ 26.98万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10701072
  • 财政年份:
    2022
  • 资助金额:
    $ 26.98万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10679092
  • 财政年份:
    2021
  • 资助金额:
    $ 26.98万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10432133
  • 财政年份:
    2021
  • 资助金额:
    $ 26.98万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10327065
  • 财政年份:
    2021
  • 资助金额:
    $ 26.98万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10377366
  • 财政年份:
    2019
  • 资助金额:
    $ 26.98万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10574496
  • 财政年份:
    2019
  • 资助金额:
    $ 26.98万
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    $ 26.98万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了